NVDA Breaks Back Through $212 as August 19 Draws Closer

Short interest is not driving this move, and that is worth stating plainly. At 1.34% of the free float — actually down slightly from last week's 1.42% reading — bears are not capitulating into a squeeze, but they were never crowded to begin with. The lending market confirms it: availability is essentially uncapped, with borrowing costs at a trivial 0.25% annually. Nothing in the positioning data signals forced buying. Short interest has ticked up roughly 11% over the past month in share terms, a marginal rebuild that argues some sellers have been adding rather than covering. Options tell a similarly relaxed story — the put/call ratio of 0.84 is a touch below its 20-day average of 0.86, well inside normal range and nowhere near the 0.97 defensive spike seen in mid-July. Neither shorts nor options traders are expressing strong conviction ahead of earnings.

The Street is broadly constructive, though recent analyst activity is starting to age. Keybanc raised its target to $330 from $310 in mid-July while holding its Overweight rating — the most recent on-record move from a named firm. The consensus mean target sits near $302, which implies roughly 43% upside from current levels. That gap is wide, but with today's price back near where it was when most of those targets were set, the premium the Street has always assigned to NVIDIA's AI infrastructure positioning looks less abstract than it did when the stock was at $190. Factor scores support the bullish structural case: the short score ranks in the 81st percentile for low short pressure, EPS momentum over 90 days ranks at 67, and days-to-cover ranks at 70. The one soft note is forward EPS growth — the 12-month forward year-over-year increase scores in just the 18th percentile, consistent with the recent note flagging that the eps_12m_fwd_yoy_increase reading of -35 introduces real caution around the earnings trajectory even as near-term momentum holds up.

Insider activity from mid-June is consistent with the pattern this stock has shown all year. CEO Jen-Hsun Huang, CFO Colette Kress, and several executive vice presidents all filed small scheduled sales on June 17. Director Mark Stevens sold a more substantial combined position — roughly $186m across three tranches in June — all at prices in the $207–$220 range, near where the stock is trading today. The net 90-day insider position is a modest positive in share terms, largely reflecting equity awards, but the directional signal from executives is one of steady, programmatic selling rather than any accumulation.

The earnings history is the most pointed input right now. The last three post-earnings reactions have all been negative: -0.5%, -3.6%, and -2.1% on the first day, with five-day moves of -3.6%, -4.1%, and -1.2% respectively. The pattern is consistent — NVIDIA has been beating estimates but disappointing on the reaction, which matters in a week when the stock is pricing back into a range that has already rejected it once. With Q2 results two weeks away, the question is whether the stock can hold above $210 in the run-up — and whether the PCR starts to reflect more defensive positioning as the date approaches.